# Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome

> **NCT00362531** · PHASE2,PHASE3 · COMPLETED · sponsor: **Peking University**

## Conditions studied

- Idiopathic Membranous Nephropathy
- Nephrotic Syndrome

## Interventions

- **DRUG:** tacrolimus combined with prednisone

## Key facts

- **NCT ID:** NCT00362531
- **Lead sponsor:** Peking University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** —
- **Final completion:** 2007-01
- **Target enrollment:** — (—)
- **Last updated:** 2006-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00362531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00362531, "Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00362531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*